One of CIAN‘s key priorities is to advocate for equitable access to vaccines and therapeutics, inclusive policies, and a safer environment for immunocompromised people to live and thrive. To advance these efforts, we have undertaken several letter-writing campaigns directed to key policymakers and stakeholders within the provincial and federal governments.
By advancing these advocacy efforts with the united voice of our patient advocates and patient organizations, we ensure that Canada’s immunocompromised community is represented at decision-maker tables.
CIAN, in collaboration with CCRAN, Save Your Skin Foundation, and 14 other patient advocacy groups, welcomed Ontario’s announcement of a pilot program to accelerate access to high-priority cancer drugs—an important first step toward improving timely treatment.
CIAN, in collaboration with the Canadian Arthritis Patient Alliance, Canadian Covid Society, and other partners, continues to advocate for access to protein-based COVID-19 vaccines, which some immunocompromised people find more tolerable.
CIAN, in collaboration with Lupus Ontario, is calling on the Ontario government to expand access to publicly funded RSV, shingles, and HPV vaccines for lupus patients and other immunocompromised individuals who face higher risks from these infections.
CIAN, as part of the Resilient Healthcare Coalition (RHC), is working alongside health system leaders to strengthen Canadian healthcare by improving data use and expanding access to innovative technologies like vaccines, diagnostics, and treatments.
Our letter to the Ontario Government expresses concern in the recent announcement to halt provincial wastewater monitoring of COVID-19 and other infectious diseases.
Our letter on protein-based COVID-19 vaccine options covers critical topics like access issues, awareness gaps, communication barriers, and skepticism.